» Articles » PMID: 28506592

Trends in Long-Term Mortality and Morbidity in Patients with No Early Complications After Stroke and Transient Ischemic Attack

Overview
Date 2017 May 17
PMID 28506592
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Advances in acute management and secondary prevention have reduced mortality and early recurrent risk after stroke and transient ischemic attack (TIA). However, whether improved outcomes are sustained long term among those without early adverse complications is not clear. We describe trends in long-term mortality and morbidity in patients with ischemic stroke or TIA who are clinically stable at 90 days.

Methods: This is a longitudinal cohort registry study (2003-2013) of patients presenting to stroke centers in Ontario, Canada, with a stroke or TIA, with no hospitalization, stroke, myocardial infarction (MI), institutionalization, or death within 90 days (N = 26,698). Primary outcomes were 1-, 3-, and 5-year age-adjusted composite rates of death, stroke or MI, and institutionalization, and secondary analyses evaluated outcomes individually. Trend tests were used to evaluate change over time.

Results: One-year adjusted composite rates decreased from 9.3% in 2003 to 7.4% in 2012 (trend test P = .02). Significant decreases in 3-year (P < .001) and 5-year (P = .002) composite rates were also observed. Rates of recurrent stroke decreased at 1 and 3 years (P < .01), but not 5 years (P = .21), whereas death rates declined across follow-up times. Conversely, rates of institutionalization increased at 3 and 5 years (P < .01).

Conclusions: Long-term mortality and morbidity post stroke and TIA have declined, confirming trends for improved long-term outcomes for patients clinically stable during the initial high-risk period. However, increased long-term rates of institutionalization also suggest that stroke and TIA patients are at risk of long-term functional decline, despite improved clinical outcomes. Further studies evaluating challenges for sustaining functional gains after stroke and TIA are required.

Citing Articles

A systematic review and meta-analysis of health utility values among patients with ischemic stroke.

Zhou J, Wei Q, Hu H, Liu W, Guan X, Ma A Front Neurol. 2023; 14:1219679.

PMID: 37731850 PMC: 10507900. DOI: 10.3389/fneur.2023.1219679.


Trends in 1-Year Recurrent Ischemic Stroke in the US Medicare Fee-for-Service Population.

Leifheit E, Wang Y, Goldstein L, Lichtman J Stroke. 2022; 53(11):3338-3347.

PMID: 36214126 PMC: 11059192. DOI: 10.1161/STROKEAHA.122.039438.


Long-Term Trends in The 5-Year Risk of Recurrent Stroke over A Half Century in A Japanese Community: The Hisayama Study.

Nakanishi Y, Furuta Y, Hata J, Yubi T, Oishi E, Sakata S J Atheroscler Thromb. 2022; 29(12):1759-1773.

PMID: 35185108 PMC: 9881531. DOI: 10.5551/jat.63344.


Hydrogen-Rich Water Improves Cognitive Ability and Induces Antioxidative, Antiapoptotic, and Anti-Inflammatory Effects in an Acute Ischemia-Reperfusion Injury Mouse Model.

Lee D, Choi J Biomed Res Int. 2021; 2021:9956938.

PMID: 34746315 PMC: 8566066. DOI: 10.1155/2021/9956938.


Acute ischemic stroke biomarkers: a new era with diagnostic promise?.

Bsat S, Halaoui A, Kobeissy F, Moussalem C, El Houshiemy M, Kawtharani S Acute Med Surg. 2021; 8(1):e696.

PMID: 34745637 PMC: 8552525. DOI: 10.1002/ams2.696.